Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Biomedical Journal|June 27, 2021
RASopathies: From germline mutations to somatic and multigenic diseasesQuentin Riller, Frédéric Rieux-Laucat
Advances in Experimental Medicine and Biology|October 29, 2020
Tight Interplay Between Therapeutic Monoclonal Antibodies and the Tumour Microenvironment in Cancer TherapyQuentin Riller, Aditi Varthaman, Sophie Sibéril
Immunological Reviews|September 28, 2024
Protective role of antibodies in enteric virus infections: Lessons from primary and secondary immune deficienciesQuentin Riller, Muriel Schmutz, Jacques Fourgeaud, et al.
The Journal of Investigative Dermatology|December 21, 2023
A20 Haploinsufficiency: A Systematic Review of 177 CasesInès Elhani, Quentin Riller, Guilaine Boursier, et al.
Intensive Care Medicine|September 29, 2021
External validation of prognostic scores for COVID-19: a multicenter cohort study of patients hospitalized in Greater Paris University HospitalsYannis Lombardi, Loris Azoyan, Piotr Szychowiak, et al.
Journal of Neurology|February 11, 2019
Infliximab biosimilar for treating neurosarcoidosis: tolerance and efficacy in a retrospective study including switch from the originator and initiation of treatmentQuentin Riller, Camille Cotteret, Helga Junot, et al.
Clinical Immunology (Orlando, Fla.)|February 29, 2024
A large deletion in a non-coding regulatory region leads to NFKB1 haploinsufficiency in two adult siblingsMathieu Fusaro, Cyrille Coustal, Laura Barnabei, et al.
Frontiers in Immunology|February 21, 2022
Case Report: Cerebral Nocardiosis Caused by Nocardia cyriacigeorgica Detected by Metagenomics in an Apparently Immunocompetent PatientVirginie Courbin, Quentin Riller, Jean-Louis Amegnizin, et al.
British Journal of Haematology|September 5, 2024
Long-term assessment of haematological recovery following somatic genetic rescue in a MYSM1-deficient patient: Implications for in vivo gene therapySophie de Tocqueville, Emmanuel Martin, Quentin Riller, et al.
Journal of Nephrology|October 8, 2022
Induction therapy for pediatric onset class IV lupus nephritis: Mycophenolate Mofetil versus CyclophosphamideMarwa Chbihi, Laurye-Anne Eveillard, Quentin Riller, et al.
Pageof 3